rsv enflonsia - Search News

Order byBest matchMost fresh

News

FDA, RSV and Enflonsia

Pulmonology Advisor · 13h

Enflonsia Approved for RSV Disease Prevention in Infants

The FDA has approved Enflonsia (clesrovimab-cfor) for the prevention of RSV lower respiratory tract disease in neonates and infants who are born during or entering their first RSV season.

Continue reading

Scripps News on MSN · 1d

FDA Approves Merck’s Enflonsia to prevent RSV in infants

Clinical Trials Arena · 2d

MSD’s Enflonsia receives FDA approval for RSV prophylaxis

2don MSN

Newly approved antibody could offer another option for protecting infants from RSV, a common infection that can be deadly

The United States could soon have another tool in the fight against respiratory syncytial virus, an illness that’s the No. 1 ...

1d

New Antibody Shot Could Help Protect Babies From RSV

THURSDAY, June 12, 2025 (HealthDay News) — A newly approved shot could soon help protect babies from respiratory syncytial ...

Fierce Pharma4d

Merck scores FDA nod for Enflonsia, setting up RSV market battle vs. Sanofi and AstraZeneca's Beyfortus

Meanwhile, Sanofi has pointed to Beyfortus’ 75% reduction in the incidence of MALRI versus Enflosia’s figure of 60%. The ...

RSV, flu linked to 6% and 3% of kids' antibiotic prescriptions

Estimates varied from 2008 through 2018, with RSV-associated antibiotic prescribing exceeding 10% in peak RSV years and ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results